Loading Events

« All Events

Psychodynamic Psychotherapy Course: Case Presentation: Technique Across the Arc of Psychoanalytic Treatment

March 20, 2027 @ 9:00 am - 12:00 pm
$125.00

Instructor: Gretchen Suarez, L.M.H.C.

This class presents a detailed reading of a clinical case drawn fro the instructor’s board certification portfolio. Students will follow the treatment across the full are, with attentional to how theoretical understanding and clinical technique live together in practice – not in isolated vignettes  but across the sustained relationship between patient and therapist over time. The case will serve as a vehicle for examining how core concepts from across the year – listening, countertransference, transference, enactment, rupture and repair – operate in a real complex clinical relationship.

Details

  • Date: March 20, 2027
  • Time:
    9:00 am - 12:00 pm
  • Cost: $125.00
  • Event Category:

Venue

  • Zoom link to be provided

Tickets

The numbers below include tickets for this event already in your cart. Clicking "Get Tickets" will allow you to edit any existing attendee information as well as change ticket quantities.
Tickets will be available on January 1, 2027

ACCME Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Psychoanalytic Association and The Florida Psychoanalytic Center. The American Psychoanalytic Association is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement: The American Psychoanalytic Association designates this live activity for a maximum of 3 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement: The APsA CE Committee has reviewed the materials for accredited continuing education and has determined that this activity is not related to the product line of ineligible companies and therefore, the activity meets the exception outlined in Standard 3: ACCME’s identification, mitigation and disclosure of relevant financial relationship. This activity does not have any known commercial support.